West Pharmaceutical Services (WST) Stock News
$WST · NYSE · HEALTHCARE · 1 stories in 30 daysBORSA has published 1 story on West Pharmaceutical Services (WST) in the past 30 days, 1 of it high impact. BORSA’s news read on WST is bullish at 75/100, −1 over 24 hours, based on 1 company event over the past 7 days. WST last closed at $403.64 on Oct 28, up 2.58% over five sessions and up 7.17% over the past month. West Pharmaceutical Services last reported quarterly results on Jul 23, 2026, for the quarter ended Jun 30, 2026.
The wire on $WST
newest first · updated · direct subject stories onlyWest Pharmaceutical Services reported Q3 net sales of $874.5 million, up 8.7% year-over-year, with adjusted-diluted EPS of $2.66, up 35.7%. The company raised its full-year 2026 net sales guidance to $3.41-$3.42 billion and adjusted-diluted EPS guidance to $9.38-$9.48. West also repurchased $231 million of stock in the quarter.
bullish 80 · impact 80The wire on this name is open. What the tape did about it is one free account away.
One free account opens every story complete, the live board and the 30-day calendar, and 3 complete ticker and report views a day. No card. The wire stays free to read.
West Pharmaceutical Services (WST) stock: common questions
What is the latest West Pharmaceutical Services stock news?
The highest-impact WST story BORSA published in the past 30 days:
·